Custom Library from Cellecta Helps Identify BRM/SMARCA2 as a Critical Target in Cancers

Dr. Gregory Hoffman's group from Novartis recently used a custom library from Cellecta that identified BRM/SMARCA2 as a critical target in BRG1-deficient cancers (PMID: 24520176). The shRNA library consisted of 6500 shRNAs (380 genes with 17 shRNAs per gene) involved in epigenetic regulation. These genes represented primarily druggable targets involved in covalent modification of histones and proteins with reader domains recognizing histone marks. This barcoded custom library was screened against 58 cancer cell lines representing various diverse genetic backgrounds.

The SWI/SNF complex is a nucleosome remodeling complex that destabilizes histone-DNA interactions and also acts as a tumor suppressor. An estimated 20% of all cancers are affected by mutations in genes in the SWI/SNF complex. Both BGI/SMARCA4 and BRM/SMARCA2 are catalytic proteins in the SWI/SNF complex. Here they found that BRM/SMARCA2 depletion caused cell cycle arrest, induction of senescence and increased levels of H3K9me3, which is typically expressed in constitutively repressed genes. They further provide insight into the mechanism of BRG1/BRM synthetic lethality in vivo using inducible shRNA constructs to BRM in BRG1-mutant tumors.

Many mutations in the SWI/SNF complex are inactivating, which makes studying these mutations a challenge. This study provides an excellent example of how a customized shRNA library can be used to provide mechanistic insight into epigenetic changes involved in cancer.


Leave a comment

Comments will be approved before showing up.


Also in Cellecta Blog & News

Core Population of Cancer Stem Cells Mediates Therapeutic Resistance in Tumors

Researchers at MD Anderson Cancer Center recently used a Cellecta CloneTracker Barcode Library to label patient-derived xenograft (PDX) cells and establish a stable population of aggressive tumorigenic cells with a specific set of barcodes. With this population of barcoded tumorigenic clones, the investigators...
Read More
DriverMap™ Targeted RNA Sequencing of Blood Finds Gene Signatures Linked to Labor

A recent article demonstrates the unique suitability of the DriverMap Expression Profiling Assay for blood biomarker analysis. In Scientific Reports, Tarca, et al. reported that DriverMap Targeted RNA sequencing identified more potential biomarkers associated with spontaneous labor than either standard Illumina...
Read More
Cellecta Scribe™ Vectors Enable RNA-Seq Analysis of Pooled CRISPR and RNAi Screens

Earlier this year, 3 separate studies (Adamson, et al., Datlinger, et al., and Dixit, et al.) demonstrated an approach to combine pooled CRISPR genetic screening with RNA expression profiling at the single-cell level. Integrating these two approaches enables knockout-specific expression data to be generated for...
Read More